GS
BHVN icon

GTS Securities’s Biohaven BHVN Stock Holding History

GTS Securities’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,800
Closed -$481K – 3930
2024
Q1 		$481K Buy
8,800
+300
+4% +$14.9K ﹤0.01% 2614
2023
Q4 		$364K Sell
8,500
-1,400
-14% -$43.5K ﹤0.01% 3047
2023
Q3 		$257K Buy
+9,900
New +$206K ﹤0.01% 3194

Other funds holding BHVN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

GTS Securities's BHVN Position: Q2 2024 in Review

GTS Securities sold out of Biohaven (BHVN) in Q2 2024, closing a stake of 8,874 shares — an estimated $351K sold.

GTS Securities first reported a position in BHVN in Q1 2024 and held it in 1 quarter. The position peaked at $485K in Q1 2024. 225 funds tracked by Wall St. Rank hold BHVN as of Q2 2024.

  • GTS Securities reported no remaining Biohaven position as of Q2 2024 after selling out during the quarter.
  • GTS Securities sold 8,874 Biohaven shares in Q2 2024, an estimated $351K.
  • GTS Securities first reported a position in Biohaven in Q1 2024 and held it in 1 quarter.
  • GTS Securities's Biohaven position peaked at $485K in Q1 2024.
  • 225 funds tracked by Wall St. Rank held Biohaven as of Q2 2024.

Based on GTS Securities's 13F filing for Q2 2024, filed 14 Aug 2024.